Description
Established in 2009, Osage University Partners is a venture capital firm based in Bala Cynwyd, Pennsylvania. The firm seeks to invest in software, technology, life science, hardware, therapeutics, medical devices, and diagnostics sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Delfi Diagnostics | 18-Jul-2022 | Early Stage VC | 00000 | Biotechnology | Generating Revenue | |
000000 0000 | 30-Jun-2022 | 00000 00000 | 000.00 | Application Specific Semiconductors | Generating Revenue | 00000 00000000 00.0 |
000000 00000000000 | 29-Jun-2022 | 00000 00000 | 00000 | Drug Delivery | Generating Revenue | |
0000000000000000 | 20-Jun-2022 | 00000 00000 | 0000 | Therapeutic Devices | Generating Revenue | 0000000 0000000000 00 |
0000000 0000000000 | 15-Jun-2022 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
0000000000 0000000 | 21-Apr-2022 | 0000 00000 | 000 | Drug Discovery | Startup | |
000000000 000000 | 24-Mar-2022 | 00000 00000 | 0000 | Environmental Services (B2B) | Startup | |
000000 | 24-Jan-2022 | 00000 00000 | 00000 | Application Specific Semiconductors | Generating Revenue | |
IMMvention Therapeutix | 19-Nov-2021 | Seed Round | 00.00 | Biotechnology | Pre-Clinical Trials | 0000000 00000 00.0 |
Blade Therapeutics | 08-Nov-2021 | PIPE | 0000 | Drug Discovery | Generating Revenue |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Urjanet | 24-May-2022 | Merger/Acquisition | |
00000000000 0000 | 07-Feb-2022 | 000000000000000000 | |
0000 | 30-Sep-2021 | 0000000 000000 | 00000 |
0000 000000000 | 15-Sep-2021 | 000 | 00000 |
00000000 000000000 | 26-Aug-2021 | 0000000 000000 | 00000 |
000000 | 10-Aug-2021 | 000000000000000000 | 0000 |
00000000000 | 27-Jul-2021 | 000000000000000000 | |
00000 0000000000 | 19-Jul-2021 | 0000000 000000 | 00000 |
Sera Prognostics | 15-Jul-2021 | IPO | 0000 |
Aerovate Therapeutics | 30-Jun-2021 | IPO | 00000 |
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Marc Singer | Co-Founder & Managing Partner, Technology | 00 | 0 | 0 | Bala Cynwyd, PA |
William Harrington MD | Managing Partner, Life Science | 00 | 0 | 0 | Bala Cynwyd, PA |
Matthew Cohen Ph.D | Partner, Life Science | 0 | 0 | 0 | Bala Cynwyd, PA |
Kirsten Leute | Partner, University Relations | Bala Cynwyd, PA | |||
Anurag Agarwal Ph.D | Principal, Life Science | Bala Cynwyd, PA |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
OrbiMed | 11 | 0 | 0 |
![]() |
![]() |
RA Capital Management | 0 | 0 | 0 |
![]() |
![]() |
Cormorant Asset Management | 0 | 0 | 0 |
![]() |
![]() |
Alexandria Venture Investments | 0 | 0 |
![]() |
![]() |
|
Johnson & Johnson Innovation - JJDC | 0 | 0 |
![]() |
![]() |